KCMF1 antibody (C-Term)
Quick Overview for KCMF1 antibody (C-Term) (ABIN952992)
Target
See all KCMF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 287-316, C-Term
-
Specificity
- This antibody recognizes Human and Mouse KCMF1 (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 287-316 amino acids from the C-terminal region of human KCMF1.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- KCMF1 (Potassium Channel Modulatory Factor 1 (KCMF1))
-
Alternative Name
- KCMF1
-
Background
- Has intrinsic E3 ubiquitin ligase activity and promotes ubiquitination.Synonyms: E3 ubiquitin-protein ligase KCMF1, FGF-induced in gastric cancer, FIGC, KCMF1, PCMF, Potassium channel modulatory factor, ZZ-type zinc finger-containing protein 1, ZZZ1
-
Molecular Weight
- 41945 Da
-
Gene ID
- 56888
-
NCBI Accession
- NP_064507
Target
-